JP2023504734A5 - - Google Patents
Info
- Publication number
- JP2023504734A5 JP2023504734A5 JP2022534147A JP2022534147A JP2023504734A5 JP 2023504734 A5 JP2023504734 A5 JP 2023504734A5 JP 2022534147 A JP2022534147 A JP 2022534147A JP 2022534147 A JP2022534147 A JP 2022534147A JP 2023504734 A5 JP2023504734 A5 JP 2023504734A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- cells
- cell
- beads
- bioreactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944346P | 2019-12-05 | 2019-12-05 | |
| US62/944,346 | 2019-12-05 | ||
| PCT/US2020/063378 WO2021113685A2 (en) | 2019-12-05 | 2020-12-04 | Regulatory t cell (treg) compositions and methods for treating neurodegenerative disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504734A JP2023504734A (ja) | 2023-02-06 |
| JP2023504734A5 true JP2023504734A5 (enExample) | 2024-02-14 |
Family
ID=74104193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534147A Pending JP2023504734A (ja) | 2019-12-05 | 2020-12-04 | 制御性Ｔ細胞（Ｔｒｅｇ）組成物及び神経変性疾患を治療するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230047159A1 (enExample) |
| EP (1) | EP4069259A2 (enExample) |
| JP (1) | JP2023504734A (enExample) |
| AU (1) | AU2020397893A1 (enExample) |
| CA (1) | CA3159411A1 (enExample) |
| MX (1) | MX2022006674A (enExample) |
| WO (1) | WO2021113685A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3221900A1 (en) * | 2021-06-08 | 2022-12-15 | Stanley Hersh Appel | Methods for producing regulatory t cell (treg) populations, treg compositions and methods for treatment |
| WO2024233788A2 (en) * | 2023-05-09 | 2024-11-14 | The Mclean Hospital Corporation | Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| JP5602133B2 (ja) * | 2009-04-24 | 2014-10-08 | 株式会社林原 | 細胞障害活性及び免疫抑制活性を併せ持つヒトｔ細胞集団の製造方法 |
| CN109715196A (zh) * | 2016-06-13 | 2019-05-03 | 转矩医疗股份有限公司 | 用于促进免疫细胞功能的组合物和方法 |
-
2020
- 2020-12-04 US US17/292,423 patent/US20230047159A1/en active Pending
- 2020-12-04 EP EP20830430.3A patent/EP4069259A2/en active Pending
- 2020-12-04 WO PCT/US2020/063378 patent/WO2021113685A2/en not_active Ceased
- 2020-12-04 AU AU2020397893A patent/AU2020397893A1/en active Pending
- 2020-12-04 MX MX2022006674A patent/MX2022006674A/es unknown
- 2020-12-04 CA CA3159411A patent/CA3159411A1/en active Pending
- 2020-12-04 JP JP2022534147A patent/JP2023504734A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6574823B2 (ja) | Ｎｋ細胞の増殖 | |
| Putnam et al. | Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation | |
| CA2446981C (fr) | Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene | |
| JP2020518289A5 (enExample) | ||
| JP2018533373A5 (enExample) | ||
| JP2015133997A (ja) | 養子細胞療法のための細胞を培養する方法 | |
| JP2023504734A5 (enExample) | ||
| JP2004527263A (ja) | 免疫抑制活性を有するエクスビボ単離ｃｄ２５＋ｃｄ４＋ｔ細胞とその使用 | |
| US20010031253A1 (en) | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease | |
| JP2011505378A (ja) | 生体外増殖させたｃｄ４＋ｃｄ２５＋制御性ｔ細胞を用いて移植片対宿主病の影響を低減するための方法 | |
| WO2001038494A1 (en) | Method of proliferating natural killer cells | |
| US20080063652A1 (en) | Methods for Production of Regulatory T Cells and Uses Thereof | |
| CA2529941C (fr) | Procede d'identification de lymphocytes tr1 regulateurs par la presence et la surexpression de molecules specifiques et ses applications | |
| Li et al. | Identification of the subsets of IL-10-producing regulatory B cells in the course of tolerance induction and maintenance in islet allotransplantation | |
| Wu et al. | Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations | |
| Pothoven et al. | Rapamycin-conditioned donor dendritic cells differentiate CD4+ CD25+ Foxp3+ T cells in vitro with TGF-β1 for islet transplantation | |
| Alonso-Guallart et al. | Characterization, biology, and expansion of regulatory T cells in the Cynomolgus macaque for preclinical studies | |
| CN104109653A (zh) | 利用无动物血清培养体系大规模扩增人外周血dnt细胞的方法 | |
| Yamazaki et al. | Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice | |
| CN102391982A (zh) | 一种体外诱导人羊膜间充质干细胞分化为胰岛素分泌细胞的方法 | |
| JP2025502150A5 (enExample) | ||
| CN112553157B (zh) | 一种淋巴细胞的扩增体系及扩增方法 | |
| KR101757269B1 (ko) | 자가유래 apc를 이용한 조절 t 세포의 생체외 증식 방법 및 이의 용도 | |
| Huh et al. | Functional improvement of pig islet with exocrine encapsulation | |
| MX2021011375A (es) | Cultivos de linfocitos t cd28, composiciones y métodos para su uso. |